Security key
00847L100
- Security type / class
- Equity / COM
- Total 13F shares
- 23,414,839
- Total 13F value
- $133,464,314
- Share change
- -594,336
- SEC-reported price per share
- $5.70
- Number of holders
- 66
- Value change
- -$3,408,392
- Number of buys
- 31
- Number of sells
- 16
Report period
Q4 2016
Institutions
66
Top holders
10
AGRX full security history
Ownership snapshot
Full 13F holder table
AGILE THERAPEUTICS INC SEC filings
AGILE THERAPEUTICS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of AGRX - AGILE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ProQuest Associates IV LLC
Disclosed value leader
ProQuest Associates IV LLC
Comparable rows
0/15
Latest evidence
30 Sep 2016
13F
Highest disclosed value: $35,335,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ProQuest Associates IV LLC has the largest disclosed position value at $35.34M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ProQuest Associates IV LLC's linked filing trail.
Disclosed position value
Top 5
ProQuest Associates IV LLC
$35.34M
INVESTOR AB
$24.5M
Aisling Capital LLC
$15.88M
Vivo Capital, LLC
$14.1M
CAXTON CORP
$12.38M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ProQuest Associates IV LLC |
13F
Company
|
—
denominator unverified
|
$35,335,000
5,062,363 shares
|
— | 30 Sep 2016 |
| INVESTOR AB |
13F
Company
|
—
denominator unverified
|
$24,501,000
3,510,189 shares
|
— | 30 Sep 2016 |
| Aisling Capital LLC |
13F
Company
|
—
denominator unverified
|
$15,883,000
2,275,455 shares
|
— | 30 Sep 2016 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$14,099,000
2,019,955 shares
|
— | 30 Sep 2016 |
| CAXTON CORP |
13F
Company
|
—
denominator unverified
|
$12,385,000
1,774,319 shares
|
— | 30 Sep 2016 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
—
denominator unverified
|
$11,866,000
1,700,000 shares
|
— | 30 Sep 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
23,414,839
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
56
Q4 2016 holders
66
Holder diff
10
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 value | Q4 2016 value | Value change | Value Chg % |
|---|